Location History:
- Jerusalem, 97289, IL (2002)
- Jerusalem, IL (2024)
Company Filing History:
1 out of 4 
1 out of 832,812 Years Active: 2002-2024
Title: Morris C Laster: Innovator in Cancer Therapy
Introduction
Morris C Laster is a notable inventor based in Jerusalem, IL. He has made significant contributions to the field of cancer therapy through his innovative patents. With a total of 2 patents, Laster's work focuses on enhancing the efficacy of treatments for cancer patients.
Latest Patents
Laster's latest patents include a groundbreaking invention titled "IL-31 improves efficacy of macrophage-based adoptive cell therapy for cancer." This invention provides genetically modified macrophages that express IL-31 or both IL-31 and a chimeric antigen receptor (CAR) for cancer treatment. It also outlines methods for administering IL-31 alongside genetically unmodified macrophages or those modified to express a CAR. Another significant patent is "Bone marrow as a site for transplantation," which relates to a process for culturing cells by introducing them into the bone or bone marrow of a mammal. This invention also describes a method for delivering biologically active substances, including nucleic acids, vectors, proteins, or pharmaceutical compositions, into the bone or bone marrow of a mammal.
Career Highlights
Throughout his career, Laster has worked with various companies, including Oncohost Ltd. His innovative approaches and dedication to improving cancer therapies have positioned him as a key figure in the field.
Collaborations
Laster has collaborated with notable individuals, including Lindsay Rosenwald, to further advance his research and innovations.
Conclusion
Morris C Laster's contributions to cancer therapy through his patents demonstrate his commitment to improving patient outcomes. His innovative work continues to influence the field and offers hope for future advancements in cancer treatment.